These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30012290)
1. The Basic Science of Dupuytren Disease. Zhang AY; Kargel JS Hand Clin; 2018 Aug; 34(3):301-305. PubMed ID: 30012290 [TBL] [Abstract][Full Text] [Related]
2. Wnt pathway in Dupuytren disease: connecting profibrotic signals. van Beuge MM; Ten Dam EJ; Werker PM; Bank RA Transl Res; 2015 Dec; 166(6):762-771.e3. PubMed ID: 26470681 [TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene. Bayat A; Watson JS; Stanley JK; Ferguson MW; Ollier WE Plast Reconstr Surg; 2003 Jun; 111(7):2133-9. PubMed ID: 12794452 [TBL] [Abstract][Full Text] [Related]
4. Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives. Cordova A; Tripoli M; Corradino B; Napoli P; Moschella F J Hand Surg Br; 2005 Dec; 30(6):557-62. PubMed ID: 16168532 [TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease. Becker K; Siegert S; Toliat MR; Du J; Casper R; Dolmans GH; Werker PM; Tinschert S; Franke A; Gieger C; Strauch K; Nothnagel M; Nürnberg P; Hennies HC; PLoS One; 2016; 11(7):e0158101. PubMed ID: 27467239 [TBL] [Abstract][Full Text] [Related]
6. [Role of fibroblasts in physiologic, reparative and pathologic processes]. Salamon A; Toldy E Orv Hetil; 2007 Sep; 148(36):1683-90. PubMed ID: 17766219 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evidence for Zic1 coexpression with beta-catenin in the myofibroblast of Dupuytren disease. Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S Scand J Plast Reconstr Surg Hand Surg; 2009; 43(1):36-40. PubMed ID: 19153880 [TBL] [Abstract][Full Text] [Related]
8. [Dupuytren's disease: state of knowledge and research in physiopathology]. Carvalhana G; Auquit-Auckbur I; Milliez PY Chir Main; 2011 Sep; 30(4):239-45. PubMed ID: 21592840 [TBL] [Abstract][Full Text] [Related]
9. Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren's contracture. Viil J; Maasalu K; Mäemets-Allas K; Tamming L; Lõhmussaar K; Tooming M; Ingerpuu S; Märtson A; Jaks V Arthritis Res Ther; 2015 May; 17(1):144. PubMed ID: 26018562 [TBL] [Abstract][Full Text] [Related]
10. Cellular structure and biology of Dupuytren's disease. Tomasek JJ; Vaughan MB; Haaksma CJ Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239 [TBL] [Abstract][Full Text] [Related]
11. A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis. Ng M; Thakkar D; Southam L; Werker P; Ophoff R; Becker K; Nothnagel M; Franke A; Nürnberg P; Espirito-Santo AI; Izadi D; Hennies HC; Nanchahal J; Zeggini E; Furniss D Am J Hum Genet; 2017 Sep; 101(3):417-427. PubMed ID: 28886342 [TBL] [Abstract][Full Text] [Related]
12. Response of dupuytren fibroblasts to different oxygen environments. Türker T; Murphy E; Kaufman CL; Kutz JE; Meister EA; Hoying JB J Hand Surg Am; 2013 Dec; 38(12):2365-9. PubMed ID: 24140364 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency may stimulate fibroblasts in Dupuytren's disease via mitochondrial increased reactive oxygen species through upregulating transforming growth factor-β1. Seyhan H; Stromps JP; Demir E; Fuchs PC; Kopp J Med Hypotheses; 2018 Jul; 116():40-41. PubMed ID: 29857907 [TBL] [Abstract][Full Text] [Related]
16. Dupuytren's disease therapy: targeting the vicious cycle of myofibroblasts? Musumeci M; Vadalà G; Russo F; Pelacchi F; Lanotte A; Denaro V Expert Opin Ther Targets; 2015; 19(12):1677-87. PubMed ID: 26690790 [TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway. Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824 [TBL] [Abstract][Full Text] [Related]
18. The Molecular Pathogenesis of Dupuytren Disease: Review of the Literature and Suggested New Approaches to Treatment. Sayadi LR; Alhunayan D; Sarantopoulos N; Kong C; Condamoor S; Sayadi J; Banyard DA; Shaterian A; Leis A; Evans GRD; Widgerow AD Ann Plast Surg; 2019 Nov; 83(5):594-600. PubMed ID: 31232804 [TBL] [Abstract][Full Text] [Related]
19. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat. Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932 [TBL] [Abstract][Full Text] [Related]
20. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence. Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]